Persium Advisors’s Eli Lilly LLY Stock Holding History

Persium Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$372K	Sell	310 -5	-2%	-$5.11K	0.24%	57
2026 Q1	$290K	Sell	315 -25	-7%	-$25.3K	0.23%	52
2025 Q4	$365K	Buy	+340	New	+$325K	0.26%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Persium Advisors's LLY Position: Q2 2026 in Review

Persium Advisors reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $5.11K and leaving 310 shares worth $372K. The position accounts for 0.24% of the portfolio, ranked #57.

Persium Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Persium Advisors held 310 shares of Eli Lilly worth $372K as of Q2 2026.
Persium Advisors sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
Eli Lilly made up 0.24% of Persium Advisors's portfolio in Q2 2026, its #57 holding.
Persium Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Persium Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.